Atea Pharmaceuticals Inc (AVIR)

Atea Pharmaceuticals Inc. has seen no insider trading activity in the last 90 days. The most recent transaction occurred on May 18, 2025, involving a purchase of shares. Prior to this, insider activity was characterized by a series of sales by various directors and executives throughout 2024.
Ticker: AVIR Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Atea Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Buy 18 May 2025
Value US$1,332,460.35 | Price 67.02 | Shares 76,003 (+21.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-20 2025-05-18 B Purchase Non-Executive Director
76,003 +21.8%
67.02
US$1,332,460
76,003 +21.8% 67.02 US$1,332,460
2024-12-12 2024-12-10 S Sale Non-Executive Director
28,351 +37.3%
345.80
US$3,417,050
28,351 +37.3% 345.80 US$3,417,050
2024-12-10 2024-12-10 PrS Proposed sale

Lead Independent Director

Non-Executive Director
57,426
310.65
US$680,021
57,426 310.65 US$680,021
2024-09-19 2024-09-19 PrS Proposed sale

Affiliate

1,841
4.00
US$7,367
1,841 4.00 US$7,367
2024-09-19 2024-09-19 S Sale

President, CEO, and Chairman

Executive Director
1,841 -0.0%
4.00
US$7,367
1,841 -0.0% 4.00 US$7,367
2024-09-19 2024-09-18 S Sale

President, CEO, and Chairman

Executive Director
22,187 -0.4%
4.03
US$89,469
22,187 -0.4% 4.03 US$89,469
2024-09-18 2024-09-18 PrS Proposed sale

Affiliate

22,187
4.03
US$89,469
22,187 4.03 US$89,469
2024-09-19 2024-09-17 S Sale

President, CEO, and Chairman

Executive Director
33,941 -0.6%
4.05
US$137,318
33,941 -0.6% 4.05 US$137,318
2024-09-17 2024-09-17 PrS Proposed sale

Affiliate

33,941
4.05
US$137,318
33,941 4.05 US$137,318
2024-06-21 2024-06-20 S Sale Non-Executive Director
17,544 -21.1%
3.49
US$61,144
17,544 -21.1% 3.49 US$61,144
2024-06-20 2024-06-20 PrS Proposed sale

Director

Non-Executive Director
17,544
3.92
US$68,772
17,544 3.92 US$68,772
2024-06-07 2024-06-05 S Sale

President, CEO, and Chairman

Executive Director
1,006 -0.0%
4.00
US$4,024
1,006 -0.0% 4.00 US$4,024
2024-06-05 2024-06-05 PrS Proposed sale

Affiliate

1,006
4.00
US$4,024
1,006 4.00 US$4,024
2024-02-02 2024-02-01 PlS Planned sale

Chief Development Officer

Officer
14,029 -28.4%
3.84
US$53,913
14,029 -28.4% 3.84 US$53,913
2024-02-02 2024-02-01 PlS Planned sale

Chief Medical Officer

Officer
15,870 -38.2%
3.84
US$60,963
15,870 -38.2% 3.84 US$60,963
2024-02-02 2024-02-01 PlS Planned sale

EVP, Chief Accounting Officer

Officer
12,477 -37.4%
3.84
US$47,904
12,477 -37.4% 3.84 US$47,904
2024-02-02 2024-02-01 PlS Planned sale

President, CEO, and Chairman

Executive Director
56,910 -32.8%
3.85
US$218,819
56,910 -32.8% 3.85 US$218,819
2024-02-02 2024-02-01 PlS Planned sale

See Remarks

Officer
15,843 -2.3%
3.84
US$60,915
15,843 -2.3% 3.84 US$60,915
2024-02-02 2024-02-01 PlS Planned sale

Chief Commercial Officer

Officer
11,819 -35.5%
3.84
US$45,420
11,819 -35.5% 3.84 US$45,420
2024-02-01 2024-02-01 PrS Proposed sale

EVP, Chief Accounting Officer

Officer
14,311
4.07
US$58,246
14,311 4.07 US$58,246
2024-02-01 2024-02-01 PrS Proposed sale

President, CEO, and Chairman

65,476
4.07
US$266,487
65,476 4.07 US$266,487
2024-02-01 2024-02-01 PrS Proposed sale

Chief Development Officer

Officer
16,110
4.07
US$65,568
16,110 4.07 US$65,568
2024-02-01 2024-02-01 PrS Proposed sale

Chief Commercial Officer

Officer
13,552
4.07
US$55,157
13,552 4.07 US$55,157
2024-02-01 2024-02-01 PrS Proposed sale

Chief Medical Officer

Officer
18,227
4.07
US$74,184
18,227 4.07 US$74,184
2024-02-01 2024-02-01 PrS Proposed sale

CFO, EVP, Legal and Secretary

18,198
4.07
US$74,066
18,198 4.07 US$74,066
2022-11-15 2022-11-14 S Sale Non-Executive Director
16,166 -2.0%
5.16
US$83,352
16,166 -2.0% 5.16 US$83,352
2022-11-15 2022-11-11 S Sale Non-Executive Director
25,500 -3.1%
5.15
US$131,333
25,500 -3.1% 5.15 US$131,333
2021-12-21 2021-12-20 B Purchase Non-Executive Director
12,000 +106.2%
8.57
US$102,796
12,000 +106.2% 8.57 US$102,796
2020-11-04 2020-11-03 B Purchase Large shareholder
7,292 +2.6%
24.00
US$175,008
7,292 +2.6% 24.00 US$175,008
2020-11-04 2020-11-03 B Purchase Large shareholder
242,708 +17.2%
24.00
US$5,824,992
242,708 +17.2% 24.00 US$5,824,992
2020-11-03 2020-11-03 B Purchase Non-Executive Director
41,666 +5.4%
24.00
US$999,984
41,666 +5.4% 24.00 US$999,984
2020-11-03 2020-11-03 B Purchase Non-Executive Director
250,000 +4.7%
24.00
US$6,000,000
250,000 +4.7% 24.00 US$6,000,000